Figure 4From: Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel PFS and OS curves for TP negative & TUBB3 positive and TP positive & TUBB3 negative patients receiving capecitabine plus paclitaxel.Back to article page